Therapeutic Potential of Splice-Switching Oligonucleotides-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Potential of Splice-Switching Oligonucleotides

Published:2009-03 Issue:1 Volume:19 Page:1-13
ISSN:1545-4576
Container-title:Oligonucleotides
language:en
Short-container-title:Oligonucleotides

Author:

Bauman John¹,Jearawiriyapaisarn Natee²,Kole Ryszard³

Affiliation:

1. Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina.

2. Thalassemia Research Center and Institute of Molecular Biology and Genetics, Mahidol University, Bangkok, Thailand.

3. AVI Biopharma, Inc., Corvallis, Oregon.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/oli.2008.0161

Reference97 articles.

1. Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients

2. Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense

3. Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells

4. Exploring the Frontiers of Therapeutic Exon Skipping for Duchenne Muscular Dystrophy by Double Targeting within One or Multiple Exons

5. Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases;Genes;2024-06-21

2. Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes;EMBO Molecular Medicine;2024-03-06

3. Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells;Biomedicines;2023-12-13

4. mCherry on Top: A Positive Read-Out Cellular Platform for Screening DMD Exon Skipping Xenopeptide–PMO Conjugates;Bioconjugate Chemistry;2023-11-22

5. Development of nucleic acid medicines based on chemical technology;Advanced Drug Delivery Reviews;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3